| Stomach | Liver | Lung |
---|
gender
| M/F | M/F | M/F |
cases
b
| 1482 | 540 | 524 |
φ
m
c
|
6.66
| 38.58 | 16.90 |
ca D
φ
> 0
d
| 1412 | 172 | 494 |
LRT
lin-con
e
| 2.09 | 11.21 | 2.26 |
ERR
1,φ
fg
| 0.09 (-0.03, 0.22) | 0.69 (0.25, 1.26) | 0.16 (-0.05, 0.42) |
Dev
h
| 1680.64 | 1258.02 | 1052.43 |
Chi-sq
i
| 3205.08 | 2389.85 | 2500.37 |
df
j
| 2992 | 2992 | 2992 |
Excess
k
| 38.13 | 27.17 | 23.20 |
|
Colon
|
Uterus
|
All solid
|
gender
| M/F | F | M/F |
cases
b
| 214 | 263 | 4379 |
φ
m
c
|
43.91
|
6.12
| 43.86 |
ca D
φ
> 0
d
| 33 | 262 | 365 |
LRT
lin-con
e
| 0.19 | 0.51 | 5.03 |
ERR
1, φ
fg
| 0.17 (-0.44, 1.17) | 0.10 (-0.16, 0.44) | 0.26 (0.03, 0.52) |
Dev
h
| 719.80 | 638.46 | 2133.03 |
Chi-sq
i
| 3497.50 | 1010.56 | 2769.51 |
df
j
| 2992 | 1513 | 2992 |
Excess
k
| 1.51 | 8.88 | 25.01 |
-
a0 – 20 mSv subcohort, Excess Relative Risk ERR = βDφ with β constrained by 1 + ERR ≥ 0 for all data cells. Dφ is the weighted adjusted colon dose (neutron RBE = 10), lagged by φ years, in 10 mSv units. The control model is nested by β = 0.
-
bdeaths in the subcohort from the specified cancer
-
cLatency φm is chosen in the range 5 – 44 years. to minimise linear model Deviance for the given cancer site and gender. Where italicised, φm minimises Dev subject to ERR ≥ 0, equivalent to β ≥ 0
-
ddeaths in the subcohort from the specified cancer, for which Dφ > 0 where φ = φm
-
eThe likelihood ratio test LRTlin-con compares the fitted linear model with the control model at φm and is χ2 distributed on 1 degree of freedom
-
fERR1,φ is the Excess Relative Risk at Dφ = 1 with φ = φm
-
g95% Profile Likelihood Confidence Intervals are calculated with φ fixed at φm
-
hDeviance of the fitted model
-
iPearson Chi-Square of the fitted model
-
jDegrees of Freedom of the fitted model
-
kdifference between Observed (= Expected) cases and the number expected if Dφ is set to 0 in every cell after fitting the model